$SYNA
SYNAPTICS Inc Stock $syna

$syna Overview Financials Valuation SEC Filings Company Website

2023 Q3 Form 10-K Financial Statement

#000095017023043521 Filed on August 18, 2023

Income Statement

Concept	2023 Q3	2023 Q2	2023
Revenue	$237.7M	$227.3M	$1.355B
YoY Change	-46.95%	-52.29%	-22.11%
Cost Of Revenue	$130.6M	$126.1M	$639.2M
YoY Change	-32.12%	-40.04%	-19.76%
Gross Profit	$107.1M	$101.2M	$715.9M
YoY Change	-58.11%	-61.97%	-24.09%
Gross Profit Margin	45.06%	44.52%	52.83%
Selling, General & Admin	$42.30M	$46.20M	$175.0M
YoY Change	-5.37%	20.63%	3.92%
% of Gross Profit	39.5%	45.65%	24.44%
Research & Development	$86.50M	$84.50M	$351.2M
YoY Change	-3.35%	-10.2%	-4.38%
% of Gross Profit	80.77%	83.5%	49.06%
Depreciation & Amortization	$30.50M	$8.500M	$35.40M
YoY Change	-27.21%	-6.59%	-8.53%
% of Gross Profit	28.48%	8.4%	4.94%
Operating Expenses	$134.3M	$139.2M	$561.6M
YoY Change	-6.54%	-1.63%	-5.25%
Operating Profit	-$27.20M	-$38.00M	$154.3M
YoY Change	-124.29%	-130.5%	-55.96%
Interest Expense	-$5.400M	-$6.300M	$55.50M
YoY Change	-178.26%	-29.21%	83.77%
% of Operating Profit			35.97%
Other Income/Expense, Net			$300.0K
YoY Change			-76.92%
Pretax Income	-$40.60M	-$44.30M	$126.0M
YoY Change	-139.15%	-138.45%	-60.69%
Income Tax	$15.00M	-$20.90M	$52.40M
% Of Pretax Income			41.59%
Net Earnings	-$55.60M	-$23.40M	$73.60M
YoY Change	-186.07%	-128.23%	-71.42%
Net Earnings / Revenue	-23.39%	-10.29%	5.43%
Basic Earnings Per Share			$1.86
Diluted Earnings Per Share	-$1.43	-$0.59	$1.83
COMMON SHARES
Basic Shares Outstanding	38.58M	39.52M	39.60M
Diluted Shares Outstanding			40.20M

Balance Sheet

Concept	2023 Q3	2023 Q2	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$824.4M	$934.3M	$934.3M
YoY Change	-9.59%	6.66%	6.66%
Cash & Equivalents	$801.3M	$924.7M	$924.7M
Short-Term Investments	$23.10M	$9.600M	$9.600M
Other Short-Term Assets	$41.30M	$36.60M	$36.60M
YoY Change	13.15%	2.81%	2.81%
Inventory	$131.7M	$137.2M	$137.2M
Prepaid Expenses
Receivables	$111.2M	$163.9M	$163.9M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$1.109B	$1.272B	$1.272B
YoY Change	-21.48%	-9.36%	-9.36%
LONG-TERM ASSETS
Property, Plant & Equipment	$67.40M	$66.40M	$66.40M
YoY Change	6.31%	5.56%	5.56%
Goodwill	$816.4M	$816.4M
YoY Change	1.21%	1.21%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$219.8M	$109.1M	$158.1M
YoY Change	71.72%	-18.58%	-19.01%
Total Long-Term Assets	$38.30M	$1.339B	$1.339B
YoY Change	-97.29%	-7.93%	-7.93%
TOTAL ASSETS
Total Short-Term Assets	$1.109B	$1.272B	$1.272B
Total Long-Term Assets	$38.30M	$1.339B	$1.339B
Total Assets	$2.549B	$2.611B	$2.611B
YoY Change	-9.77%	-8.63%	-8.63%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$63.90M	$45.80M	$45.80M
YoY Change	-48.88%	-67.7%	-67.7%
Accrued Expenses	$103.0M	$154.3M	$154.3M
YoY Change	-19.66%	-34.59%	-34.59%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$6.000M	$6.000M	$6.000M
YoY Change	0.0%	0.0%	0.0%
Total Short-Term Liabilities	$245.5M	$260.1M	$260.1M
YoY Change	-32.79%	-43.87%	-43.87%
LONG-TERM LIABILITIES
Long-Term Debt	$969.6M	$972.0M	$972.0M
YoY Change	-0.53%	-0.38%	-0.38%
Other Long-Term Liabilities	$129.3M	$135.9M	$135.9M
YoY Change	-18.98%	-10.94%	-10.94%
Total Long-Term Liabilities	$1.099B	$1.108B	$1.108B
YoY Change	-3.13%	-1.81%	-1.81%
TOTAL LIABILITIES
Total Short-Term Liabilities	$245.5M	$260.1M	$260.1M
Total Long-Term Liabilities	$1.099B	$1.108B	$1.108B
Total Liabilities	$1.344B	$1.368B	$1.368B
YoY Change	-10.36%	-14.05%	-14.05%
SHAREHOLDERS EQUITY
Retained Earnings	$1.057B	$1.112B
YoY Change	-4.22%	7.09%
Common Stock	$1.026B	$1.009B
YoY Change	10.08%	9.21%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$878.0M	$878.0M
YoY Change	24.03%	26.42%
Treasury Stock Shares
Shareholders Equity	$1.204B	$1.243B	$1.243B
YoY Change
Total Liabilities & Shareholders Equity	$2.549B	$2.611B	$2.611B
YoY Change	-9.77%	-8.63%	-8.63%

Cashflow Statement

Concept	2023 Q3	2023 Q2	2023
OPERATING ACTIVITIES
Net Income	-$55.60M	-$23.40M	$73.60M
YoY Change	-186.07%	-128.23%	-71.42%
Depreciation, Depletion And Amortization	$30.50M	$8.500M	$35.40M
YoY Change	-27.21%	-6.59%	-8.53%
Cash From Operating Activities	$45.40M	$94.50M	$331.5M
YoY Change	-42.17%	-26.17%	-28.36%
INVESTING ACTIVITIES
Capital Expenditures	$136.7M	$5.200M	$34.20M
YoY Change	2104.84%	-223.81%	9.97%
Acquisitions			$15.50M
YoY Change			-96.91%
Other Investing Activities	-$13.40M	$27.30M	$29.10M
YoY Change	-257.65%	58.72%	-106.84%
Cash From Investing Activities	-$150.1M	$22.10M	-$6.000M
YoY Change	-6626.09%	70.0%	-98.76%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$183.5M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-18.10M	-87.10M	-221.3M
YoY Change	-48.29%	3250.0%	-1647.55%
NET CHANGE
Cash From Operating Activities	45.40M	94.50M	331.5M
Cash From Investing Activities	-150.1M	22.10M	-6.000M
Cash From Financing Activities	-18.10M	-87.10M	-221.3M
Net Change In Cash	-122.8M	29.50M	100.7M
YoY Change	-380.37%	-78.68%	-918.7%
FREE CASH FLOW
Cash From Operating Activities	$45.40M	$94.50M	$331.5M
Capital Expenditures	$136.7M	$5.200M	$34.20M
Free Cash Flow	-$91.30M	$89.30M	$297.3M
YoY Change	-226.28%	-32.45%	-31.12%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-26
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0000817720
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2021	us-gaap	Lessee Operating Lease Existence Of Option To Extend LesseeOperatingLeaseExistenceOfOptionToExtend	true
CY2023Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2022Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax
CY2023Q2	us-gaap	Operating Lease Liability Statement Of Financial Position Extensible List OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#LongTermDebtNoncurrent
CY2022Q2	us-gaap	Operating Lease Liability Statement Of Financial Position Extensible List OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#LongTermDebtNoncurrent
CY2023Q2	us-gaap	Operating Lease Liability Statement Of Financial Position Extensible List OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#LongTermDebtNoncurrent
CY2022Q2	us-gaap	Operating Lease Liability Statement Of Financial Position Extensible List OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#LongTermDebtNoncurrent
CY2023	us-gaap	Stock Repurchase Program Expiration Date StockRepurchaseProgramExpirationDate	2025-07-31
CY2021	syna	Unrecognized Tax Benefits Decreases Resulting From Remeasurement UnrecognizedTaxBenefitsDecreasesResultingFromRemeasurement
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-06-24
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	000-49602
CY2023	dei	Entity Registrant Name EntityRegistrantName	SYNAPTICS INCORPORATED
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	77-0118518
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	1109 McKay Drive
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	San Jose
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	95131
CY2023	dei	City Area Code CityAreaCode	(408
CY2023	dei	Local Phone Number LocalPhoneNumber	904-1100
CY2023	dei	Security12b Title Security12bTitle	Common Stock, par value $.001 per share
CY2023	dei	Trading Symbol TradingSymbol	SYNA
CY2023	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	false
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2022Q4	dei	Entity Public Float EntityPublicFloat	3263436621000000
CY2023Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	38584203
CY2023	dei	Auditor Name AuditorName	KPMG LLP
CY2023	dei	Auditor Location AuditorLocation	Santa Clara, California
CY2023	dei	Auditor Firm AuditorFirmId	185
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	924700000
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	824000000.0
CY2023Q2	us-gaap	Short Term Investments ShortTermInvestments	9600000
CY2022Q2	us-gaap	Short Term Investments ShortTermInvestments	52000000.0
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	5000000.0
CY2022Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	6000000.0
CY2023Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	163900000
CY2022Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	322100000
CY2023Q2	us-gaap	Inventory Net InventoryNet	137200000
CY2022Q2	us-gaap	Inventory Net InventoryNet	169700000
CY2023Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	36600000
CY2022Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	35600000
CY2023Q2	us-gaap	Assets Current AssetsCurrent	1272000000.0
CY2022Q2	us-gaap	Assets Current AssetsCurrent	1403400000
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	66400000
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	62900000
CY2023Q2	us-gaap	Goodwill Goodwill	816400000
CY2022Q2	us-gaap	Goodwill Goodwill	806600000
CY2023Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	298500000
CY2022Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	390000000.0
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	49000000.0
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	61200000
CY2023Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	109100000
CY2022Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	134000000.0
CY2023Q2	us-gaap	Assets Assets	2611400000
CY2022Q2	us-gaap	Assets Assets	2858100000
CY2023Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	45800000
CY2022Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	141800000
CY2023Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	45900000
CY2022Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	90600000
CY2023Q2	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	54000000.0
CY2022Q2	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	79700000
CY2023Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	108400000
CY2022Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	145300000
CY2023Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	6000000.0
CY2022Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	6000000.0
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	260100000
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	463400000
CY2023Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	972000000.0
CY2022Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	975700000
CY2023Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	135900000
CY2022Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	152600000
CY2023Q2	us-gaap	Liabilities Liabilities	1368000000.0
CY2022Q2	us-gaap	Liabilities Liabilities	1591700000
CY2022Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000
CY2023Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000
CY2022Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2023Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2022Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2023Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2023Q2	us-gaap	Preferred Stock Value PreferredStockValue	0
CY2022Q2	us-gaap	Preferred Stock Value PreferredStockValue	0
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	120000000
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	120000000
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	68687511
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	67745800
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	38571072
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	39621179
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	100000
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	100000
CY2023Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1009200000
CY2022Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	924100000
CY2023Q2	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	30116439
CY2022Q2	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	28124621
CY2023Q2	us-gaap	Treasury Stock Value TreasuryStockValue	878000000.0
CY2022Q2	us-gaap	Treasury Stock Value TreasuryStockValue	694500000
CY2023Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	0
CY2022Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1800000
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	1112100000
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	1038500000
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	1243400000
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	1266400000
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2611400000
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2858100000
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1355100000
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1739700000
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1339600000
CY2023	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	639200000
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	796600000
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	728400000
CY2023	us-gaap	Gross Profit GrossProfit	715900000
CY2022	us-gaap	Gross Profit GrossProfit	943100000
CY2021	us-gaap	Gross Profit GrossProfit	611200000
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	351200000
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	367300000
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	313400000
CY2023	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	175000000.0
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	168400000
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	144900000
CY2023	syna	Amortization Of Intangible Assets Included In Operating Expense AmortizationOfIntangibleAssetsIncludedInOperatingExpense	35400000
CY2022	syna	Amortization Of Intangible Assets Included In Operating Expense AmortizationOfIntangibleAssetsIncludedInOperatingExpense	38700000
CY2021	syna	Amortization Of Intangible Assets Included In Operating Expense AmortizationOfIntangibleAssetsIncludedInOperatingExpense	32700000
CY2023	us-gaap	Restructuring Charges RestructuringCharges	0
CY2022	us-gaap	Restructuring Charges RestructuringCharges	18300000
CY2021	us-gaap	Restructuring Charges RestructuringCharges	7400000
CY2023	us-gaap	Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets	0
CY2022	us-gaap	Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets	0
CY2021	us-gaap	Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets	34200000
CY2023	us-gaap	Operating Expenses OperatingExpenses	561600000
CY2022	us-gaap	Operating Expenses OperatingExpenses	592700000
CY2021	us-gaap	Operating Expenses OperatingExpenses	464200000
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	154300000
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	350400000
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	147000000.0
CY2023	us-gaap	Interest Income Other InterestIncomeOther	27200000
CY2022	us-gaap	Interest Income Other InterestIncomeOther	3000000.0
CY2021	us-gaap	Interest Income Other InterestIncomeOther	2900000
CY2023	us-gaap	Interest Expense InterestExpense	55500000
CY2022	us-gaap	Interest Expense InterestExpense	30200000
CY2021	us-gaap	Interest Expense InterestExpense	29500000
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-8100000
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-300000
CY2023	us-gaap	Sale And Leaseback Transaction Gain Loss Net SaleAndLeasebackTransactionGainLossNet	0
CY2022	us-gaap	Sale And Leaseback Transaction Gain Loss Net SaleAndLeasebackTransactionGainLossNet	5400000
CY2021	us-gaap	Sale And Leaseback Transaction Gain Loss Net SaleAndLeasebackTransactionGainLossNet	0
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	126000000.0
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	320500000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	120100000
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	52400000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	64600000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	31400000
CY2023	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	0
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	1600000
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-9100000
CY2023	us-gaap	Net Income Loss NetIncomeLoss	73600000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	257500000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	79600000
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.86
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	6.60
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.29
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.83
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	6.33
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.08
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	39600000
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	39000000.0
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	34800000
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	40200000
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	40700000
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	38300000
CY2023	us-gaap	Net Income Loss NetIncomeLoss	73600000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	257500000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	79600000
CY2023	syna	Other Comprehensive Income Loss Unrealized Available For Sale Securities OtherComprehensiveIncomeLossUnrealizedAvailableForSaleSecurities	-600000
CY2022	syna	Other Comprehensive Income Loss Unrealized Available For Sale Securities OtherComprehensiveIncomeLossUnrealizedAvailableForSaleSecurities	1800000
CY2021	syna	Other Comprehensive Income Loss Unrealized Available For Sale Securities OtherComprehensiveIncomeLossUnrealizedAvailableForSaleSecurities	0
CY2023	syna	Reclassification Adjustments For Losses Included In Net Income ReclassificationAdjustmentsForLossesIncludedInNetIncome	1200000
CY2022	syna	Reclassification Adjustments For Losses Included In Net Income ReclassificationAdjustmentsForLossesIncludedInNetIncome	0
CY2021	syna	Reclassification Adjustments For Losses Included In Net Income ReclassificationAdjustmentsForLossesIncludedInNetIncome	0
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	1800000
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-1800000
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	75400000
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	255700000
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	79600000
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	819100000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	79600000
CY2021	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	27800000
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	-28.3
CY2021	syna	Issuance Of Treasury Stock For Redemption Of Convertible Notes IssuanceOfTreasuryStockForRedemptionOfConvertibleNotes	-300000
CY2021	syna	Share Based Compensation Attributable To Acquisition ShareBasedCompensationAttributableToAcquisition	3200000
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	66100000
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	967200000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	257500000
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-1800000
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	15200000
CY2022	syna	Issuance Of Treasury Stock For Redemption Of Convertible Notes IssuanceOfTreasuryStockForRedemptionOfConvertibleNotes	-6900000
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	-67.3
CY2022	syna	Share Based Compensation Attributable To Acquisition ShareBasedCompensationAttributableToAcquisition	1700000
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	100800000
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	1266400000
CY2023	us-gaap	Net Income Loss NetIncomeLoss	73600000
CY2023	us-gaap	Other Comprehensive Income Other Net Of Tax OtherComprehensiveIncomeOtherNetOfTax	1800000
CY2023	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	17600000
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	-54.5
CY2023	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	183500000
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	122000000.0
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	1243400000
CY2023	us-gaap	Profit Loss ProfitLoss	73600000
CY2022	us-gaap	Profit Loss ProfitLoss	257500000
CY2021	us-gaap	Profit Loss ProfitLoss	79600000
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	122000000.0
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	100800000
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	66100000
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	27400000
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	24000000.0
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	21600000
CY2023	syna	Acquired Intangibles Amortization AcquiredIntangiblesAmortization	130400000
CY2022	syna	Acquired Intangibles Amortization AcquiredIntangiblesAmortization	123500000
CY2021	syna	Acquired Intangibles Amortization AcquiredIntangiblesAmortization	110100000
CY2023	us-gaap	Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets	0
CY2022	us-gaap	Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets	0
CY2021	us-gaap	Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets	34200000
CY2023	syna	Gain On Sale And Leaseback Transaction GainOnSaleAndLeasebackTransaction	0
CY2022	syna	Gain On Sale And Leaseback Transaction GainOnSaleAndLeasebackTransaction	5400000
CY2021	syna	Gain On Sale And Leaseback Transaction GainOnSaleAndLeasebackTransaction	0
CY2023	syna	Loss On Redemption Of Convertible Notes LossOnRedemptionOfConvertibleNotes	0
CY2022	syna	Loss On Redemption Of Convertible Notes LossOnRedemptionOfConvertibleNotes	-8100000
CY2021	syna	Loss On Redemption Of Convertible Notes LossOnRedemptionOfConvertibleNotes	-300000
CY2023	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	25900000
CY2022	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	29700000
CY2021	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	5200000
CY2023	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	2600000
CY2022	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	3400000
CY2021	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	19800000
CY2023	syna	Change In Operating Lease Right Of Use Asset ChangeInOperatingLeaseRightOfUseAsset	9700000
CY2022	syna	Change In Operating Lease Right Of Use Asset ChangeInOperatingLeaseRightOfUseAsset	10800000
CY2021	syna	Change In Operating Lease Right Of Use Asset ChangeInOperatingLeaseRightOfUseAsset	8600000
CY2023	syna	Amortization Of Cost Of Development Services AmortizationOfCostOfDevelopmentServices	5800000
CY2022	syna	Amortization Of Cost Of Development Services AmortizationOfCostOfDevelopmentServices	10000000.0
CY2021	syna	Amortization Of Cost Of Development Services AmortizationOfCostOfDevelopmentServices	9200000
CY2023	syna	Provision For Inventory Excess And Obsolescence ProvisionForInventoryExcessAndObsolescence	7900000
CY2022	syna	Provision For Inventory Excess And Obsolescence ProvisionForInventoryExcessAndObsolescence	-10900000
CY2021	syna	Provision For Inventory Excess And Obsolescence ProvisionForInventoryExcessAndObsolescence	9700000
CY2023	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	0
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	1600000
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-9100000
CY2023	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-1700000
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	7600000
CY2021	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	2800000
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	300000
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1300000
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	0
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-161300000
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	81100000
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	25900000
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-24600000
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	54200000
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-43400000
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	6100000
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-6900000
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	9400000
CY2023	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-9400000
CY2022	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-15000000.0
CY2021	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	8600000
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-95600000
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	23200000
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	32200000
CY2023	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-45400000
CY2022	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	5300000
CY2021	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	14900000
CY2023	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-15600000
CY2022	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	48600000
CY2021	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-2100000
CY2023	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	-56000000.0
CY2022	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	17400000
CY2021	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	-17200000
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	331500000
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	462700000
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	319200000
CY2023	us-gaap	Proceeds From Sales Of Assets Investing Activities ProceedsFromSalesOfAssetsInvestingActivities	200000
CY2022	us-gaap	Proceeds From Sales Of Assets Investing Activities ProceedsFromSalesOfAssetsInvestingActivities	55900000
CY2021	us-gaap	Proceeds From Sales Of Assets Investing Activities ProceedsFromSalesOfAssetsInvestingActivities	0
CY2023	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	15500000
CY2022	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	501100000
CY2021	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	626500000
CY2023	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	0
CY2022	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	30000000.0
CY2021	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	0
CY2023	syna	Proceeds From Sale Of Audio Technology Assets ProceedsFromSaleOfAudioTechnologyAssets	0
CY2022	syna	Proceeds From Sale Of Audio Technology Assets ProceedsFromSaleOfAudioTechnologyAssets	0
CY2021	syna	Proceeds From Sale Of Audio Technology Assets ProceedsFromSaleOfAudioTechnologyAssets	34200000
CY2023	syna	Proceeds From Maturity Of Investments ProceedsFromMaturityOfInvestments	-21400000
CY2022	syna	Proceeds From Maturity Of Investments ProceedsFromMaturityOfInvestments	0
CY2021	syna	Proceeds From Maturity Of Investments ProceedsFromMaturityOfInvestments	0
CY2023	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	22200000
CY2022	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	24400000
CY2021	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	95800000
CY2023	us-gaap	Proceeds From Payments For Trading Securities ProceedsFromPaymentsForTradingSecurities	0
CY2022	us-gaap	Proceeds From Payments For Trading Securities ProceedsFromPaymentsForTradingSecurities	-5800000
CY2021	us-gaap	Proceeds From Payments For Trading Securities ProceedsFromPaymentsForTradingSecurities	0
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	34200000
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	31100000
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	21100000
CY2023	syna	Receipt Of Liquidation Payment On Equity Investment ReceiptOfLiquidationPaymentOnEquityInvestment	800000
CY2022	syna	Receipt Of Liquidation Payment On Equity Investment ReceiptOfLiquidationPaymentOnEquityInvestment	0
CY2021	syna	Receipt Of Liquidation Payment On Equity Investment ReceiptOfLiquidationPaymentOnEquityInvestment	0
CY2023	us-gaap	Indefinite Lived Intangible Assets Purchase Accounting Adjustments IndefiniteLivedIntangibleAssetsPurchaseAccountingAdjustments	-900000
CY2022	us-gaap	Indefinite Lived Intangible Assets Purchase Accounting Adjustments IndefiniteLivedIntangibleAssetsPurchaseAccountingAdjustments	0
CY2021	us-gaap	Indefinite Lived Intangible Assets Purchase Accounting Adjustments IndefiniteLivedIntangibleAssetsPurchaseAccountingAdjustments	0
CY2023	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments	0
CY2022	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments	5000000.0
CY2021	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments	0
CY2023	syna	Payment For Cost Method Investment PaymentForCostMethodInvestment	0
CY2022	syna	Payment For Cost Method Investment PaymentForCostMethodInvestment	0
CY2021	syna	Payment For Cost Method Investment PaymentForCostMethodInvestment	5000000.0
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-6000000.0
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-482700000
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-522600000
CY2023	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	0
CY2022	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	600000000.0
CY2021	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	400000000.0
CY2023	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0
CY2022	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	11200000
CY2021	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	6000000.0
CY2023	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	17600000
CY2022	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	15200000
CY2021	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	27800000
CY2023	syna	Payment For Payroll Taxes For Deferred Stock And Market Stock Units PaymentForPayrollTaxesForDeferredStockAndMarketStockUnits	54500000
CY2022	syna	Payment For Payroll Taxes For Deferred Stock And Market Stock Units PaymentForPayrollTaxesForDeferredStockAndMarketStockUnits	67300000
CY2021	syna	Payment For Payroll Taxes For Deferred Stock And Market Stock Units PaymentForPayrollTaxesForDeferredStockAndMarketStockUnits	28300000
CY2023	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	183500000
CY2022	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0
CY2021	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0
CY2023	us-gaap	Proceeds From Repayments Of Secured Debt ProceedsFromRepaymentsOfSecuredDebt	-6000000.0
CY2022	us-gaap	Proceeds From Repayments Of Secured Debt ProceedsFromRepaymentsOfSecuredDebt	-3000000.0
CY2021	us-gaap	Proceeds From Repayments Of Secured Debt ProceedsFromRepaymentsOfSecuredDebt	-100000000.0
CY2023	syna	Payment For Redemption Of Convertible Notes PaymentForRedemptionOfConvertibleNotes	0
CY2022	syna	Payment For Redemption Of Convertible Notes PaymentForRedemptionOfConvertibleNotes	-505600000
CY2021	syna	Payment For Redemption Of Convertible Notes PaymentForRedemptionOfConvertibleNotes	-19400000
CY2023	syna	Refundable Deposit Paid To Vendor RefundableDepositPaidToVendor	0
CY2022	syna	Refundable Deposit Paid To Vendor RefundableDepositPaidToVendor	-16600000
CY2021	syna	Refundable Deposit Paid To Vendor RefundableDepositPaidToVendor	0
CY2023	syna	Return Of Deposit Received From Vendor ReturnOfDepositReceivedFromVendor	5100000
CY2022	syna	Return Of Deposit Received From Vendor ReturnOfDepositReceivedFromVendor	2800000
CY2021	syna	Return Of Deposit Received From Vendor ReturnOfDepositReceivedFromVendor	0
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-221300000
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	14300000
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	274100000
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-3500000
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-6600000
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2200000
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	100700000
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-12300000
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	72900000
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	824000000.0
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	836300000
CY2020Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	763400000
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	924700000
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	824000000.0
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	836300000
CY2023	us-gaap	Proceeds From Income Tax Refunds ProceedsFromIncomeTaxRefunds	91400000
CY2022	us-gaap	Proceeds From Income Tax Refunds ProceedsFromIncomeTaxRefunds	38300000
CY2021	us-gaap	Proceeds From Income Tax Refunds ProceedsFromIncomeTaxRefunds	39400000
CY2023	us-gaap	Interest Paid Net InterestPaidNet	51900000
CY2022	us-gaap	Interest Paid Net InterestPaidNet	25000000.0
CY2021	us-gaap	Interest Paid Net InterestPaidNet	9600000
CY2023	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	2200000
CY2022	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	3600000
CY2021	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	800000
CY2023	syna	Receipt Of Intangible Assets From Advance Payment Made In Previous Fiscal Year ReceiptOfIntangibleAssetsFromAdvancePaymentMadeInPreviousFiscalYear	30000000.0
CY2022	syna	Receipt Of Intangible Assets From Advance Payment Made In Previous Fiscal Year ReceiptOfIntangibleAssetsFromAdvancePaymentMadeInPreviousFiscalYear	0
CY2021	syna	Receipt Of Intangible Assets From Advance Payment Made In Previous Fiscal Year ReceiptOfIntangibleAssetsFromAdvancePaymentMadeInPreviousFiscalYear	0
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;font-style:italic;min-width:fit-content;">Use of Estimates</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">The preparation of consolidated financial statements in conformity with U.S. GAAP requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenue, expenses, and related disclosure of contingent assets and liabilities. On an ongoing basis, we evaluate our estimates, including those related to revenue, allowance for doubtful accounts, cost of revenue, inventories, loss on purchase commitments, product warranty, accrued liabilities, share-based compensation costs, provision for income taxes, deferred income tax asset valuation allowances, uncertain tax positions, goodwill, intangible assets, investments, and loss contingencies. We base our estimates on historical experience, applicable laws and regulations, and various other assumptions that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.</span></p>
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	924700000
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	824000000.0
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;font-style:italic;min-width:fit-content;">Concentration of Credit Risk</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">Financial instruments that potentially subject us to concentrations of credit risk consist primarily of cash equivalents, investments, and accounts receivable. Our investment policy, which is predicated on capital preservation and liquidity, limits investments to U.S. government treasuries and agency issues, taxable securities, and municipal issued securities with a minimum rating of investment grade by the rating agencies.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">We sell our products to contract manufacturers that provide manufacturing services for OEMs, to some OEMs directly, and to distributors. We extend credit based on an evaluation of a customer’s financial condition, and we generally do not require collateral.</span></p><div style="font-size:10.0pt;font-family:"Times New Roman", serif;"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">The following customers accounted for more than 10% of our accounts receivable balance as of the end of fiscal </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">2023 and 2022:</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:66.993%;"></td> <td style="width:1.62%;"></td> <td style="width:14.883%;"></td> <td style="width:1.62%;"></td> <td style="width:14.883%;"></td> </tr> <tr style="height:8.0pt;"> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">2023</span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:"Arial", sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">2022</span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">Customer A</span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:"Times New Roman", serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">10</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">%</span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:"Times New Roman", serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">17</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">%</span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">Customer B</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:"Times New Roman", serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">20</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">%</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:"Times New Roman", serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">15</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">%</span></p></td> </tr> </table></div>
CY2023	us-gaap	Revenue Performance Obligation Description Of Payment Terms RevenuePerformanceObligationDescriptionOfPaymentTerms	Payments are generally due within three months of completion of the performance obligation and subsequent invoicing and, therefore, do not include significant financing components.
CY2023Q2	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	1300000
CY2022Q2	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	1200000
CY2023Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	18700000
CY2023Q2	us-gaap	Contract With Customer Refund Liability ContractWithCustomerRefundLiability	39800000
CY2022Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	27300000
CY2022Q2	us-gaap	Contract With Customer Refund Liability ContractWithCustomerRefundLiability	61300000
CY2023	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	21900000
CY2022	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	3600000
CY2023	syna	Account Receivable Bad Debt Charge AccountReceivableBadDebtCharge	5000000.0
CY2022	syna	Account Receivable Bad Debt Charge AccountReceivableBadDebtCharge	6000000.0
CY2023Q2	us-gaap	Inventory Work In Process And Raw Materials Net Of Reserves InventoryWorkInProcessAndRawMaterialsNetOfReserves	70500000
CY2022Q2	us-gaap	Inventory Work In Process And Raw Materials Net Of Reserves InventoryWorkInProcessAndRawMaterialsNetOfReserves	92200000
CY2023Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	66700000
CY2022Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	77500000
CY2023Q2	us-gaap	Inventory Net InventoryNet	137200000
CY2022Q2	us-gaap	Inventory Net InventoryNet	169700000
CY2023	syna	Foreign Currency Transaction Realized And Unrealized Gain Loss Net Of Tax ForeignCurrencyTransactionRealizedAndUnrealizedGainLossNetOfTax	-2300000
CY2022	syna	Foreign Currency Transaction Realized And Unrealized Gain Loss Net Of Tax ForeignCurrencyTransactionRealizedAndUnrealizedGainLossNetOfTax	-5600000
CY2021	syna	Foreign Currency Transaction Realized And Unrealized Gain Loss Net Of Tax ForeignCurrencyTransactionRealizedAndUnrealizedGainLossNetOfTax	-1400000
CY2023Q2	syna	Customer Obligation CustomerObligation	58500000
CY2022Q2	syna	Customer Obligation CustomerObligation	88600000
CY2023Q2	syna	Accrued Liabilities For Inventory Purchase AccruedLiabilitiesForInventoryPurchase	7000000.0
CY2022Q2	syna	Accrued Liabilities For Inventory Purchase AccruedLiabilitiesForInventoryPurchase	14100000
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	9000000.0
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	7600000
CY2023Q2	us-gaap	Other Sundry Liabilities Current OtherSundryLiabilitiesCurrent	33900000
CY2022Q2	us-gaap	Other Sundry Liabilities Current OtherSundryLiabilitiesCurrent	35000000.0
CY2023Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	108400000
CY2022Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	145300000
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	42400000
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	51500000
CY2023Q2	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	39100000
CY2022Q2	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	52600000
CY2023Q2	us-gaap	Accrued Income Taxes Noncurrent AccruedIncomeTaxesNoncurrent	38100000
CY2022Q2	us-gaap	Accrued Income Taxes Noncurrent AccruedIncomeTaxesNoncurrent	29100000
CY2023Q2	us-gaap	Other Sundry Liabilities Noncurrent OtherSundryLiabilitiesNoncurrent	16300000
CY2022Q2	us-gaap	Other Sundry Liabilities Noncurrent OtherSundryLiabilitiesNoncurrent	19400000
CY2023Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	135900000
CY2022Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	152600000
CY2023Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	298500000
CY2022Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	699700000
CY2022Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	309700000
CY2023Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	424800000
CY2023	us-gaap	Net Income Loss NetIncomeLoss	73600000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	257500000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	79600000
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	39600000
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	39000000.0
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	34800000
CY2023	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	600000
CY2022	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1700000
CY2021	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	3500000
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	40200000
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	40700000
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	38300000
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.86
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	6.60
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.29
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.83
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	6.33
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.08
CY2023Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	198900000
CY2022Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	185700000
CY2023Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	132500000
CY2022Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	122800000
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	66400000
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	62900000
CY2022	syna	Allocation Of Stock Based Compensation Replacement Awards AllocationOfStockBasedCompensationReplacementAwards	1700000
CY2023Q2	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	9800000
CY2023Q2	us-gaap	Debt Instrument Fair Value DebtInstrumentFairValue	9600000
CY2022Q2	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	54000000.0
CY2022Q2	us-gaap	Debt Instrument Fair Value DebtInstrumentFairValue	52000000.0
CY2023Q2	syna	Cash Held In Bank CashHeldInBank	853900000
CY2022Q2	us-gaap	Goodwill Goodwill	806600000
CY2021Q2	us-gaap	Goodwill Goodwill	570000000.0
CY2023	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	9800000
CY2022	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	236600000
CY2023Q2	us-gaap	Goodwill Goodwill	816400000
CY2022Q2	us-gaap	Goodwill Goodwill	806600000
CY2023	us-gaap	Acquired Finite Lived Intangible Assets Weighted Average Useful Life AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife	P4Y10M24D
CY2023Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	723300000
CY2022Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	390000000.0
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	130400000
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	123500000
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	110100000
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	73800000
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	66900000
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	53800000
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	23200000
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	10600000
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	3200000
CY2023Q2	syna	Finite Lived Intangible Assets Amortization Expense To Be Determined FiniteLivedIntangibleAssetsAmortizationExpenseToBeDetermined	67000000.0
CY2023Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	298500000
CY2023	syna	Redemption Of Principal Amout Percentage RedemptionOfPrincipalAmoutPercentage	1
CY2023	syna	Percentage Of Voting Capital Stock Of Certain Foreign Subsidiaries Collateralized PercentageOfVotingCapitalStockOfCertainForeignSubsidiariesCollateralized	0.65
CY2023	syna	Percentage Of Non Voting Capital Stock PercentageOfNonVotingCapitalStock	1
CY2021Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	600000000.0
	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2028-12-02
CY2021Q4	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.0100
CY2023	us-gaap	Debt Instrument Basis Spread On Variable Rate1 DebtInstrumentBasisSpreadOnVariableRate1	0.25
CY2021Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	11200000
CY2023Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	6000000.0
CY2023Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	6000000.0
CY2023Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	6000000.0
CY2023Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	6000000.0
CY2023Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	6000000.0
CY2023Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	961000000.0
CY2023Q2	us-gaap	Long Term Debt LongTermDebt	991000000.0
CY2023Q2	us-gaap	Long Term Debt LongTermDebt	991000000.0
CY2023Q2	us-gaap	Deferred Finance Costs Gross DeferredFinanceCostsGross	13000000.0
CY2023Q2	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	978000000.0
CY2022Q2	us-gaap	Long Term Debt LongTermDebt	997000000.0
CY2022Q2	us-gaap	Deferred Finance Costs Gross DeferredFinanceCostsGross	15300000
CY2022Q2	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	981700000
CY2023	us-gaap	Lessee Operating Lease Option To Extend LesseeOperatingLeaseOptionToExtend	The leases expire at various dates through fiscal year 2034, some of which include options to extend the lease for up to seven years.
CY2023	syna	Lease Expiration Year LeaseExpirationYear	2034
CY2023	us-gaap	Operating Lease Expense OperatingLeaseExpense	12000000.0
CY2022	us-gaap	Operating Lease Expense OperatingLeaseExpense	12700000
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	49000000.0
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	61200000
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	9000000.0
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	7600000
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	42400000
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	51500000
CY2023Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	51400000
CY2022Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	59100000
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	10600000
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	12500000
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	7300000
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	42500000
CY2023Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P7Y4M17D
CY2023Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0515
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	10300000
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	9900000
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	8400000
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	7400000
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	5900000
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	20200000
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	62100000
CY2023Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	10700000
CY2023Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	51400000
CY2022	us-gaap	Sale And Leaseback Transaction Gain Loss Net SaleAndLeasebackTransactionGainLossNet	5400000
CY2023Q2	syna	Accrued Amount In Contractual Dispute AccruedAmountInContractualDispute	4000000.0
CY2023Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000
CY2023Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	3994824
CY2023Q2	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	5783513
CY2023Q2	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	2300000000
CY2023Q2	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	893900000
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	31185
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	61.50
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	27545
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	62.10
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	557
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	81.88
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3083
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	52.53
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	100000
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	3083
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	52.53
CY2023Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	100000
CY2023	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	3300000
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	5300000
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	23900000
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	1600000
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	3600000
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	8600000
CY2023	us-gaap	Shares Paid For Tax Withholding For Share Based Compensation SharesPaidForTaxWithholdingForShareBasedCompensation	1300000
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.5522
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.5261
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.5362
CY2023Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	6300000
CY2023	syna	Period Over Which Share Based Compensation Is Amortized Duration PeriodOverWhichShareBasedCompensationIsAmortizedDuration	P8M
CY2022	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-7900000
CY2021	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-8400000
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-25900000
CY2023	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Amount DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount	22500000000
CY2023	syna	Defined Contribution Plans Eligible Employee Contributions Employees Fifty And Over Annual Limit DefinedContributionPlansEligibleEmployeeContributionsEmployeesFiftyAndOverAnnualLimit	30000000000
CY2023	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent Of Match DefinedContributionPlanEmployerMatchingContributionPercentOfMatch	0.25
CY2023	syna	Contributions By Employer Matching Contributions ContributionsByEmployerMatchingContributions	1900000
CY2022	syna	Contributions By Employer Matching Contributions ContributionsByEmployerMatchingContributions	1700000
CY2021	syna	Contributions By Employer Matching Contributions ContributionsByEmployerMatchingContributions	1800000
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	126000000.0
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	320500000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	120100000
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	15800000
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-600000
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	4100000
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	100000
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	0
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	100000
CY2023	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	62400000
CY2022	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	94900000
CY2021	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	36100000
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	78300000
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	94300000
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	40300000
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-12700000
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-21800000
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-500000
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0
CY2023	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-13200000
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-29700000
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-8900000
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	52400000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	64600000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	31400000
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	26400000
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	67300000
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	25100000
CY2023	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	0
CY2022	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	0
CY2021	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	100000
CY2023	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	6600000
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	7900000
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	5200000
CY2023	syna	Effective Income Tax Rate Reconciliation Share Based Compensation Shortfall Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationShortfallAmount	1300000
CY2022	syna	Effective Income Tax Rate Reconciliation Share Based Compensation Shortfall Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationShortfallAmount	18100000
CY2021	syna	Effective Income Tax Rate Reconciliation Share Based Compensation Shortfall Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationShortfallAmount	3800000
CY2023	syna	Income Tax Reconciliation Non Deductible Compensation IncomeTaxReconciliationNonDeductibleCompensation	6400000
CY2022	syna	Income Tax Reconciliation Non Deductible Compensation IncomeTaxReconciliationNonDeductibleCompensation	6400000
CY2021	syna	Income Tax Reconciliation Non Deductible Compensation IncomeTaxReconciliationNonDeductibleCompensation	6400000
CY2023	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	5200000
CY2022	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	10000000.0
CY2021	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	3800000
CY2023	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-500000
CY2022	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	6400000
CY2021	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-6700000
CY2023	us-gaap	Income Tax Reconciliation Tax Contingencies Foreign IncomeTaxReconciliationTaxContingenciesForeign	21000000.0
CY2022	us-gaap	Income Tax Reconciliation Tax Contingencies Foreign IncomeTaxReconciliationTaxContingenciesForeign	3600000
CY2021	us-gaap	Income Tax Reconciliation Tax Contingencies Foreign IncomeTaxReconciliationTaxContingenciesForeign	5200000
CY2023	us-gaap	Income Tax Reconciliation Repatriation Of Foreign Earnings IncomeTaxReconciliationRepatriationOfForeignEarnings	300000
CY2022	us-gaap	Income Tax Reconciliation Repatriation Of Foreign Earnings IncomeTaxReconciliationRepatriationOfForeignEarnings	700000
CY2021	us-gaap	Income Tax Reconciliation Repatriation Of Foreign Earnings IncomeTaxReconciliationRepatriationOfForeignEarnings	3500000
CY2023	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-1300000
CY2022	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	400000
CY2021	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	200000
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	52400000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	64600000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	31400000
CY2023Q2	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards	34100000
CY2022Q2	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards	33800000
CY2023Q2	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	1900000
CY2022Q2	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	2600000
CY2023Q2	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	42100000
CY2022Q2	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	11700000
CY2023Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	10300000
CY2022Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	12000000.0
CY2023Q2	syna	Nondeductible Interest NondeductibleInterest	4900000
CY2022Q2	syna	Nondeductible Interest NondeductibleInterest	5400000
CY2023Q2	syna	Deferred Tax Assets Lease Liabilities DeferredTaxAssetsLeaseLiabilities	10100000
CY2022Q2	syna	Deferred Tax Assets Lease Liabilities DeferredTaxAssetsLeaseLiabilities	11200000
CY2023Q2	us-gaap	Deferred Tax Assets Tax Credit Carryforwards General Business DeferredTaxAssetsTaxCreditCarryforwardsGeneralBusiness	45100000
CY2022Q2	us-gaap	Deferred Tax Assets Tax Credit Carryforwards General Business DeferredTaxAssetsTaxCreditCarryforwardsGeneralBusiness	62000000.0
CY2023Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	10800000
CY2022Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	16300000
CY2023Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther	5100000
CY2022Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther	5600000
CY2023Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	164400000
CY2022Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	160600000
CY2023Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	78400000
CY2022Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	75000000.0
CY2023Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	86000000.0
CY2022Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	85600000
CY2023Q2	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	1900000
CY2022Q2	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	2000000.0
CY2023Q2	us-gaap	Deferred Tax Liabilities Investments DeferredTaxLiabilitiesInvestments	9500000
CY2022Q2	us-gaap	Deferred Tax Liabilities Investments DeferredTaxLiabilitiesInvestments	11500000
CY2023Q2	us-gaap	Deferred Tax Liabilities Undistributed Foreign Earnings DeferredTaxLiabilitiesUndistributedForeignEarnings	14300000
CY2022Q2	us-gaap	Deferred Tax Liabilities Undistributed Foreign Earnings DeferredTaxLiabilitiesUndistributedForeignEarnings	22100000
CY2023Q2	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssets	31400000
CY2022Q2	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssets	45800000
CY2023Q2	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	57100000
CY2022Q2	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	81400000
CY2023Q2	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	28900000
CY2022Q2	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	4200000
CY2023Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	78400000
CY2023	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	3400000
CY2023Q2	us-gaap	Deferred Tax Liabilities Undistributed Foreign Earnings DeferredTaxLiabilitiesUndistributedForeignEarnings	14300000
CY2023Q2	us-gaap	Tax Cuts And Jobs Act Of2017 Transition Tax For Accumulated Foreign Earnings Liability TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsLiability	200000000
CY2023Q2	us-gaap	Undistributed Earnings Of Foreign Subsidiaries UndistributedEarningsOfForeignSubsidiaries	46000000
CY2021	us-gaap	Unrecognized Tax Benefits Period Increase Decrease UnrecognizedTaxBenefitsPeriodIncreaseDecrease	13900000
CY2022Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	29800000
CY2023Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	43700000
CY2023Q2	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	33100000
CY2022Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	29800000
CY2021Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	22600000
CY2020Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	20100000
CY2023	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	13700000
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	7100000
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	5500000
CY2023	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	2500000
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	5500000
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	0
CY2023	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	1100000
CY2022	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	0
CY2021	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	0
CY2023	syna	Unrecognized Tax Benefits Decreases Resulting From Remeasurement UnrecognizedTaxBenefitsDecreasesResultingFromRemeasurement	-300000
CY2022	syna	Unrecognized Tax Benefits Decreases Resulting From Remeasurement UnrecognizedTaxBenefitsDecreasesResultingFromRemeasurement	-500000
CY2023	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	900000
CY2022	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	4900000
CY2021	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	3000000.0
CY2023Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	43700000
CY2022Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	29800000
CY2021Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	22600000
CY2023	syna	Increase Decrease In Unrecognized Tax Benefit Income Tax Penalties And Interest Accrued IncreaseDecreaseInUnrecognizedTaxBenefitIncomeTaxPenaltiesAndInterestAccrued	500000
CY2022	syna	Increase Decrease In Unrecognized Tax Benefit Income Tax Penalties And Interest Accrued IncreaseDecreaseInUnrecognizedTaxBenefitIncomeTaxPenaltiesAndInterestAccrued	800000
CY2023Q2	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	3000000.0
CY2022Q2	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	2500000
CY2023Q2	us-gaap	Decrease In Unrecognized Tax Benefits Is Reasonably Possible DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible	1400000
CY2023Q2	us-gaap	Increase In Unrecognized Tax Benefits Is Reasonably Possible IncreaseInUnrecognizedTaxBenefitsIsReasonablyPossible	8800000
CY2023	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1
CY2023	syna	Number Of Product Categories NumberOfProductCategories	3
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1355100000
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1739700000
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1339600000
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1355100000
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1739700000
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1339600000
CY2023Q2	us-gaap	Noncurrent Assets NoncurrentAssets	1181300000
CY2022Q2	us-gaap	Noncurrent Assets NoncurrentAssets	1259500000
CY2022Q2	us-gaap	Restructuring Reserve RestructuringReserve	1400000
CY2021Q2	us-gaap	Restructuring Reserve RestructuringReserve	200000
CY2020Q2	us-gaap	Restructuring Reserve RestructuringReserve	6100000
CY2023	us-gaap	Restructuring Charges RestructuringCharges	0
CY2022	us-gaap	Restructuring Charges RestructuringCharges	18300000
CY2021	us-gaap	Restructuring Charges RestructuringCharges	7400000
CY2023	us-gaap	Payments For Restructuring PaymentsForRestructuring	1400000
CY2022	us-gaap	Payments For Restructuring PaymentsForRestructuring	17100000
CY2021	us-gaap	Payments For Restructuring PaymentsForRestructuring	13300000
CY2023Q2	us-gaap	Restructuring Reserve RestructuringReserve	0
CY2022Q2	us-gaap	Restructuring Reserve RestructuringReserve	1400000
CY2021Q2	us-gaap	Restructuring Reserve RestructuringReserve	200000
CY2023	us-gaap	Restructuring Charges RestructuringCharges	0
CY2022	us-gaap	Restructuring Charges RestructuringCharges	18300000
CY2021	us-gaap	Restructuring Charges RestructuringCharges	7400000

Files In Submission

Name	View Source	Status
0000950170-23-043521-index-headers.html	Edgar Link	pending
0000950170-23-043521-index.html	Edgar Link	pending
0000950170-23-043521.txt	Edgar Link	pending
0000950170-23-043521-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
img256951547_0.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R103.htm	Edgar Link	pending
R104.htm	Edgar Link	pending
R105.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
syna-20230624.htm	Edgar Link	pending
syna-20230624.xsd	Edgar Link	pending
syna-ex21.htm	Edgar Link	pending
syna-ex23_1.htm	Edgar Link	pending
syna-ex31_1.htm	Edgar Link	pending
syna-ex31_2.htm	Edgar Link	pending
syna-ex32_1.htm	Edgar Link	pending
syna-ex32_2.htm	Edgar Link	pending
syna-20230624_cal.xml	Edgar Link	unprocessable
syna-20230624_def.xml	Edgar Link	unprocessable
syna-20230624_lab.xml	Edgar Link	unprocessable
syna-20230624_pre.xml	Edgar Link	unprocessable
syna-20230624_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SYNA
SYNAPTICS Inc Stock $syna

2023 Q3 Form 10-K Financial Statement

#000095017023043521 Filed on August 18, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SYNA SYNAPTICS Inc Stock $syna

2023 Q3 Form 10-K Financial Statement

#000095017023043521 Filed on August 18, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SYNA
SYNAPTICS Inc Stock $syna